Latest Equity Issuance News

InFocus Group Holdings has extended its convertible note facility with Obsidian Global, unlocking up to AUD 450,000 to accelerate growth in digital assets, AI, and machine learning.

Pilot Energy has issued $600,000 in convertible notes under a previously approved $1.8 million facility with Discovery Investments, correcting a minor contractual reference without altering terms.

Barton Gold Holdings has entered binding terms to acquire the Wudinna Gold Project in South Australia, adding 279,000 ounces of gold resources to its portfolio. The $15 million transaction, largely settled in shares and milestone payments, awaits Cobra Resources shareholder approval.

Noble Helium has arranged a $200,000 unsecured loan from its Non-Executive Chair as a short-term refinancing measure, aiming to bolster working capital without diluting shareholders. The company plans a webinar to outline its refinancing and strategic direction.

Eildon Capital Group has announced the reactivation of its Dividend and Distribution Reinvestment Plan (DRP) for the upcoming half-year distribution, offering securityholders a cost-free way to reinvest dividends into additional securities.

Transurban Group has announced a 33.0 cents per stapled security distribution for the first half of FY25, alongside key dates for its 2025 Annual General Meetings.

Macarthur Minerals has clarified key details regarding its recent convertible note funding, confirming the counterparty is an independent entity and highlighting the need for shareholder approval before issuing shares on conversion.

Miramar Resources has partnered with Topdrill in a drill-for-equity agreement to fund significant drilling at the promising 8 Mile gold target within its Gidji JV Project near Kalgoorlie. Drilling is set to begin in July, aiming to explore extensions of a known gold deposit.

Peninsula Energy has resolved outstanding claims with its EPC contractor and is advancing a reset plan for its Lance uranium project, including revised production guidance and funding strategies.

Chimeric Therapeutics has secured a $2.5 million advance against its FY25 R&D tax incentive, bolstering funding for its clinical trial pipeline and operational needs. This move complements recent capital raises and underscores the company’s strategic financial management amid its oncology-focused cell therapy development.

High-Tech Metals Limited has successfully completed a modest capital raise through a non-renounceable entitlement offer, issuing shares at $0.15 each alongside free attaching options. The company now holds discretion over a significant shortfall placement, which could influence its capital structure in the coming months.

TruScreen Limited has obtained a waiver from NZ RegCo allowing it to allot oversubscribed shares up to 10 business days after its capital raising offer closes, subject to shareholder approval. This move aims to streamline the company’s NZ$3 million placement and share purchase plan.